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Microcomputed tomography (µ-CT) is a nondestructive, high-
resolution, three-dimensional method of analyzing objects. The 
aim of this study was to evaluate the feasibility of using µ-CT 
as a noninvasive method of evaluation for tissue-engineering 
applications. The polyurethane aortic heart valve scaffold was 
produced using a spraying technique. Cryopreserved/thawed 
homograft and biological heart valve were decellularized 
using a detergent mixture. Human endothelial cells and fibro-
blasts were derived from saphenous vein segments and were 
verified by immunocytochemistry. Heart valves were initially 
seeded with fibroblasts followed by colonization with endo-
thelial cells. Scaffolds were scanned by a µ-CT scanner before 
and after decellularization as well as after cell seeding. Suc-
cessful colonization was additionally determined by scanning 
electron microscopy (SEM) and immunohistochemistry (IHC). 
Microcomputed tomography accurately visualized the com-
plex geometry of heart valves. Moreover, an increase in the 
total volume and wall thickness as well as a decrease in total 
surface was demonstrated after seeding. A confluent cell distri-
bution on the heart valves after seeding was confirmed by SEM 
and IHC. We conclude that µ-CT is a new promising noninva-
sive method for qualitative and quantitative analysis of tissue- 
engineering processes. ASAIO Journal 2013;59:169–177.
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Heart valve replacement is one of the most common surgi-
cal interventions in cardiac health care.1–3 The implantation of 
mechanical or biological prostheses is currently state of the 
art in this field.4 However, both types of implants have several 
limitations that affect the patient’s quality of life.5 Biological 
substitutes tend to degenerate resulting in loss of function, thus 
indicating reoperation. Mechanical heart valves require a life-
long oral anticoagulation therapy and can be accompanied by 
severe complications.6–10 The field of tissue engineering gives 
hope to solve the deficiencies of recent heart valve prosthe-
ses. The variety of approaches to develop tissue-engineered 
heart valve prostheses is large. The promising approaches are 
the seeding of decellularized porcine or human heart valves 
and the application of synthetic materials such as polyurethane 
as scaffold materials.11–13 Seeding is most frequently achieved 
using vascular or stem cells14,15 Seeding scaffolds with autolo-
gous cells has the advantage of thrombogenicity and immu-
nogenicity when implanted.16 Decellularization success and 
seeding efficiency must be visualized in an attempt to develop 
quality control in tissue engineering. Usual techniques for 
validating cell adhesion to constructs are scanning electron 
microscopy (SEM) and immunohistochemistry (IHC). However, 
these procedures require invasive sampling and are, therefore, 
useless for later clinical application.
We suggest microcomputed tomography (µ-CT) as a new 
high-resolution, noninvasive method for feasibility testing of 
seeded heart valve.17 Computed tomography was introduced 
into clinical practice in 1972.18 This imaging technology 
enables the generation of three-dimensional images by 
computer-based stacking of two-dimensional x-ray scans after 
axial rotation around a sample.19 Today CT is used in material 
testing destruction-free examination of archeological troves, 
in veterinary medicine, and most of all in human medical 
diagnostics.17,20–23 The spatial resolution of µ-CT is 5–50 µm; 
this is up to 66-fold more precise than the resolution achieved 
by conventional CT in the clinical setting implementation 
(330 µm).24 Therefore, the aim of this study was to evaluate the 
feasibility of using µ-CT scanning as a noninvasive evaluation 
method for tissue-engineering applications, especially 
pertaining to heart valve constructs.
Materials and Methods
Heart Valve Fixation
The aortic walls of the heart valves were sutured (Supolene 
suture, Resorba Wundversorgung GmbH & Co. KG, Nürnberg, 
Germany) to the base ring of special Teflon fixation units (man-
ufactured in-house). The units consisted of two circular plates 
(outer diameter do = 4.8 cm, inner diameter di = 2.0 cm) con-
nected by four struts (height h = 4.9 cm, d = 0.6 cm) to avoid 
heart valve deformation during further processing.
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Heart Valve Types and Preparation
Polyurethane heart valve. Aortic polyurethane heart 
valves (PUHVs) (h = 55 mm, d = 18 mm) were manufactured 
by ITV-Denkendorf using a polyurethane spraying technique 
(patent DE 28 06 030 C2). Randomly oriented polyurethane 
(PU) fibers were measured to have diameters between 100 nm 
and 550 nm. The fibers formed a sheet with a thickness of 
0.3 mm. For seeding purpose, PUHV was γ-sterilized at 10 kGy 
according to a certified sterilization procedure.
Homograft. After aortic homograft (h = 50 mm, d = 19 mm) 
thawing in 56°C warm phosphate-buffered saline (PBS) 
(Biochrom AG, Berlin, Germany), cryoprotectiva were removed 
by washing once with PBS and once with M199 (Biochrom 
AG) at 56°C. The homograft was stored for 24 hours in M199 
and was decellularized by treatment of the valve with 0.5% so-
dium dodecyl sulfate and 0.5% sodium deoxycholate (Sigma–
Aldrich Chemie GmbH, Steinheim, Germany) dissolved in PBS 
for 24 hours at room temperature (RT). This was followed by six 
24-hour washing steps in which the valves were washed in PBS 
at RT to remove cellular remnants and chemicals to which the 
valves were previously exposed. The homograft was incubated 
for 24 hours in M199 medium at RT before cell seeding.
Biological heart valve. Glutaraldehyde fixation of por-
cine heart valve (h = 45 mm, d = 19 mm, Medtronic GmbH, 
Meerbusch, Germany) was neutralized by 10% citric acid 
(Merck KGaA, Darmstadt, Germany) in distilled water for 5 
minutes at RT. For a neutral pH, biological heart valve (BHV) 
was washed thrice with PBS for 15 minutes. The heart valve 
was stored in endothelial cell growth medium (Promocell 
GmbH, Heidelberg, Germany) containing 20% fetal calf se-
rum (FCS, Lonza AG, Verviers, Belgium) for 1 week at 37°C/5% 
CO2. Decellularization of BHV was analogously performed as 
described for homograft decellularization.
Cell Isolation and Cell Culture
Endothelial cells (ECs) and fibroblasts (FBs) were isolated from 
left-over human saphenous vein segments harvested for coronary 
artery bypass grafting. Samples were taken from the patients only 
after their informed consent. Veins were stored in M199 medium 
at 4°C for a maximum of 5 days until further processing. The vein 
segments were cannulated and washed with M199 medium 
containing 0.2% heparin (5000 I.E., Ratiopharm GmbH, Ulm, 
Germany) and 0.5% gentamycin (10 mg/ml, Biochrom AG). For 
EC isolation, veins were filled with 1 mg/ml collagenase II (280 
u, Worthington Biochemical Corporation, NJ) and incubated 
for 30 minutes at 37°C/5% CO2. After EC isolation, veins were 
incubated with 2 mg/ml collagenase II for 40 minutes at the same 
conditions for FB isolation. After each incubation step, collage-
nase cell solutions were rinsed out of the vein, centrifuged for 
7 minutes at 500 rpm, and cultivated in the respective growth 
media (endothelial cell growth medium: ECGM; fibroblast growth 
medium: FGM; PromoCell GmbH, Heidelberg, Germany) in cul-
ture flasks (12.5 cm2, Becton Dickinson GmbH, Heidelberg, Ger-
many) at 37°C/5% CO2. The medium was partially or completely 
exchanged every 2–3 days. Cells were passaged at confluency.
Heart Valve Seeding and Cultivation
Heart valve scaffolds were first seeded with FBs, followed by 
colonization with ECs. For both cell types, a seeding density 
of 1.5 × 106 cells/cm2 was used. To ensure a uniform cell dis-
tribution, the seeding procedure was performed in a specially 
designed rotating seeding device (running phase: 2.5 minutes, 
holding phase: 30 minutes) for 24 hours at 37°C/5% CO2. 
After FB seeding, the seeded heart valves were cultivated for 
7 days at 37°C/5% CO2 under static conditions. Medium was 
exchanged every 2–3 days. After this initial cultivation period, 
FB-seeded heart valves were analogously seeded with ECs. For 
further analysis, samples were taken from the supravalvular 
region of the aortic wall as well as from the valvular leaflets. 
Samples were taken from native, decellularized, and reseeded 
valves. The samples from the reseeded valves were taken upon 
completion of EC seeding.
Phenotypic Cell Characterization
Phenotypic determination of FBs and ECs was performed 
by morphologic classification using phase contrast micros-
copy (Carl Zeiss MikroImaging GmbH, Göttingen, Germany). 
Fibroblasts were recognized by their elongated spindle-like 
appearance.25 Endothelial cells were identified by their typi-
cal cobblestone morphology.26 Additionally, the cell types 
were verified by immunocytochemistry. Cells were seeded and 
cultured on culture slides (eight-chamber; BD Biosciences, 
Bedford). At confluency cells were fixed and stored in 96% 
ethanol (Merck KGaA) at −80°C for a minimum of 48 hours. 
Slides were washed three times with PBS (Biochrom AG) and 
endogenous peroxidase activity was subsequently blocked via 
treatment with hydrogen peroxide (Merck KGaA). Primary anti-
bodies for CD31 (ECs; 0.14 µg/ml, Dianova GmbH, Hamburg, 
Germany) and TE-7 (FBs; 0.67 µg/ml, Millipore Corp., BioSci-
ence Division, Temecula, CA) were applied, respectively, and 
the slides were incubated for 30 minutes. After washing, the 
slides were covered with biotinylated link (HRP Detection Sys-
tem, Biozol GmbH, Eching, Germany) according to manufac-
turer’s protocol and were incubated for 10 minutes. Cells were 
labeled with HRP streptavidin for 10 minutes and subsequently 
incubated with AEC-peroxidase substrate (Vector Laboratories, 
Inc., Burlingame, CA) for another 10 minutes. All steps were 
performed at RT. Cell nuclei were stained with hemalaun (1:4 
in PBS; Merck KGaA). A bright field microscope (Carl Zeiss 
MikroImaging GmbH) was used for microscopical evaluation.
Microcomputerized Tomography
Scanning procedure. For transport and µ-CT scanning, 
heart valve scaffolds were sutured to Teflon units and placed 
in a custom-fit glass container. Microcomputed tomography 
scanning of BHV was performed at RT before incubating the 
biological valve in cell medium by using the original glutar-
aldehyde-fixation solution, after decellularization and incuba-
tion in M199 medium, and finally after seeding and incuba-
tion in ECGM. The homograft was scanned at RT after thawing 
in M199 medium, after decellularization and incubation in 
M199 medium, and finally after seeding and incubation in 
ECGM. In the case of PU, scans were performed at RT on a dry 
scaffold, after seeding and incubating the scaffold for 7 days in 
FGM, and finally after seeding and incubating the scaffold for 
7 days in ECGM. To obtain the necessary high-contrast images, 
approximately 90% of the medium was drained from the glass 
container, and 10% was left to avoid dehydration of the heart 
valve scaffolds during scanning.
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Microcomputed tomography analysis allowed a noninvasive 
analysis of several positions of the scaffold heart valve types. 
The tomographic investigations were performed using a µ-CT 
machine of the type HR-150-03. The reconstructed complete 
volume of the heart valve consisted of 2048³ voxels with an edge 
length of 35 µm and was reconstructed from 1,600 individual 
x-ray radioscopy images. The detector used was a Perkin–Elmer 
flat panel detector type XRD 1621-CT3 consisting of 2048² pix-
els. The x-ray source used a tungsten target and was powered 
at 120 kV with a current of 150 µA, generating a polychromatic 
x-ray spectrum. The total exposure time was 35 minutes. In addi-
tion, a set of region of interest (ROI) measurements were per-
formed to determine the thickness of the cellular coverage. The 
ROI procedure analyzes a specific small volume of a sample at 
very high resolution, ignoring the remaining volume. The proce-
dure consists of an off-center measurement, with a focus on one 
specific region of the volume. A 360° rotation was performed 
around the ROI, resulting in high-resolution, high-contrast volu-
metric images of 9 µm, allowing the detection of thin cell layers.
For x-ray observation, heart valves do not need to be 
removed from the sterile container, offering an analysis under 
sterile conditions.
Image generation. The reconstruction of cross-sections 
was performed using a reconstruction algorithm developed by 
the Fraunhofer Institute EZRT, Fürth, Germany. Structural analy-
sis and three-dimensional visualization were carried out using 
the visualization software VG-Studio Max, version 2.1, with an 
adapted wall-thickness algorithm developed by the University 
of Bayreuth. The algorithms used to determine the wall thick-
ness are based on topographic algorithms. The algorithm first 
determines the exact surfaces of the valve (based on gray-scale 
gradients of voxels), resulting in two topographic data sets 
(e.g., inside and outside). For determining the actual thickness 
at a certain position, both topographic data sets are compared 
and used to calculate a local minimal distance vector at each 
position. The vector provides information on the direction as 
well as the local wall thickness. This approach is applied for 
each individual CT measurement. Geometric changes in the 
object are automatically correlated by applying the minimum 
distance method—any changes in the overall geometry result 
in a new set of vectors that include the geometric information 
and the new wall thickness, allowing for a direct comparison 
of different CT measurements.
The used x-ray tension was adjusted to 120 kV at 150 µA. 
The high resolution achieved (35 µm) resulted in commend-
able accuracies of 0.02 mm2 for the determination of total sur-
face area and 0.1 mm3 for the determination of total volume. 
For our application, total volume was defined as the volume 
of the complete tissue-engineered structure itself, the lumen of 
the valve was excluded from this calculation. To determine the 
thickness of the cellular coverage, regions of the heart valve 
scaffolds were additionally subjected to an ROI analysis with 
a resolution of 9 µm.
Scanning Electron Microscopy
To detect surface topography of synthetic, biological, and 
human heart valve scaffolds in native, decellularized, and 
seeded status, the samples were analyzed by SEM. Specimens 
were fixed in a solution of 456 ml aqua bidistilled (Ampuwa, 
Fresenius Kabi Deutschland GmbH, Bad Homburg v.d. H., 
Germany), 0.75 ml 1 N hydrochloric acid (Titrisol, Merck 
KGaA), 43.5 ml glutaraldehyde, and 5.65 g sodium cocodylate 
trihydrate (Sigma–Aldrich Chemie GmbH) at 4°C for a mini-
mum of 48 hours. The samples were dehydrated in an ascending 
ethanol series (30%, 50%, 70%, and 95%) and subsequently in 
100% acetone. The specimens were dried by critical point dry-
ing, sputtered with gold for 180 seconds at 10–5 mbar, and ana-
lyzed using SEM (EVO LS 10; Carl Zeiss MicroImaging GmbH).
Immunohistochemistry
Immunohistochemical analysis was performed to detect 
ECs and FBs after seeding as well as to evaluate the native and 
decellularized biological valves. Samples from native, decel-
lularized, and seeded heart valves were fixed in 4% formalde-
hyde (Microcos GmbH, Garching, Germany) for 10 days at 4°C. 
Fixed samples were paraffin-embedded and sectioned at 10 µm. 
Slices were stained for CD31 (ECs; 0.09 µg/ml; Dianova GmbH) 
and TE-7 (FBs; 2 µg/ml, Millipore Corp., BioScience Division). 
Endogenous peroxidase activity was blocked by treatment with 
hydrogen peroxide and then the samples were incubated with 
primary antibody overnight at 4°C. All the following steps were 
performed at RT. After washing with PBS, the samples were 
covered with biotinylated link for 10 minutes, and HRP Strep-
tavidin label for 10 minutes according to the manufacturer’s 
protocol (HRP Detection kit, Biozol GmbH), followed by chro-
mogen labeling for 10 minutes using AEC peroxidase substrate 
kit (Vector Laboratories, Inc.). Cell nuclei were stained with 
hemalaun (1:4 in PBS; Merck KGaA). Controls for nonspecific 
binding of the chromogen label were performed by excluding 
the primary antibody. Samples were observed using bright field 
microscopy (Carl Zeiss MikroImaging GmbH).
results
The evaluation of aortic heart valve in different states (native, 
decellularized, and seeded) was successfully achieved via µ-
CT scanning. To this end, BHV, homograft, and PUHV were 
tested by µ-CT, with special focus on the effect of seeding on 
values calculated from µ-CT data. Microcomputed tomogra-
phy analysis of homograft aortic heart valves was performed 
analogously and showed similar results (data not shown).
Topography and Seeding Analysis of BHV and Homograft
Scanning electron microscopy analysis (Figure 1A–C) of 
native (A) and in particular of the decellularized (Figure 1B) 
BHV samples showed randomly orientated fibers resulting in 
a rough surface. Decellularized BHV demonstrated a conflu-
ent cell layer after seeding procedure (Figure 1C). Moreover, 
typical cobblestone morphology indicated an EC layer. Immu-
nohistochemistry analysis (Figure 1D–F) of decellularized 
homograft (Figure 1D) did not show the presence of vascular 
cells. In contrast, reseeded homograft revealed a positive stain-
ing for CD31 and TE-7, indicating a confluent coverage with 
FBs (Figure 1E, brown) and ECs (Figure 1F, brown). Cell nuclei 
were stained with hemalaun (Figure 1D–F, purple).
Total Volume and Surface Area of BHV
Microcomputed tomography scanning of heart valve scaf-
folds was performed as described in the Materials and Methods 
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section. Microcomputed tomography analysis allowed a numeri-
cal determination as well as a graphical representation of total 
volume and surface area. Microcomputed tomography images 
in Figure 2 show cross- (A–C) and longitudinal sections (D–F) of 
native, decellularized, and reseeded BHV. A closer look revealed 
an intense thickening of the valvular leaflets (Figure 2C, arrows) 
and the aortic wall (Figure 2F, arrows) in the reseeded state.
Quantitative analysis revealed a 0.5% decrease in total volume 
and 0.2% increase in surface area after decellularization of BHV. 
In contrast, the analysis of seeded BHV after successful decel-
lularization revealed an 8.6% increase in volume and a 0.3% 
decrease in surface area. Single values are summarized in Table 1.
Thickness Alteration of BHV
Changes in thickness during BHV processing were deter-
mined by the comparison of reconstructed cross-sections of 
the same valve and the same section plane in different states. 
Figure 3 demonstrates the native (A), decellularized (B), and 
reseeded (C) states of BHV. The four circular areas represent 
the Teflon struts of the heart valve fixation unit. At four posi-
tions, thicknesses are exemplary determined. The native state 
of BHV (Figure 3A) revealed a decrease in thickness compared 
with the decellularized state (Figure 3B). The analysis of the 
reseeded state (Figure 3C) compared with the decellularized 
and native state shows an increase in thickness at correspond-
ing positions.
Wall Thicknesses of BHV
Wall thicknesses were volumetrically determined by using 
tangential analysis of the raw data. The thicknesses of the leaflets 
(Figure 4A–C) and of the aortic regions (Figure 4D–F) in native, 
decellularized, and reseeded status are color coded. Different 
Figure 2. Cross- (A–C) and longitudinal (D–F) sections of native, decellularized, and reseeded biological heart valve from micro-computed 
tomography scan. Reseeded samples showed a distinct increase in the thickness of the valvular leaflets (C, arrows) and the aortic wall (F, 
arrows). These are representative images of three independent experiments. Scale bars: A–C = 5 mm; D–F = 10 mm.
Figure 1. Scanning electron microscopy (SEM) and immunohistochemistry (IHC) analysis of biological heart valve (BHV) and homograft in 
different states of processing. SEM analysis of native (A) and decellularized (B) samples of BHV showed disordered fibers resulting in a rough 
surface. In contrast, reseeded samples (C) revealed a confluent endothelial layer. The acellularity of decellularized homograft samples was 
confirmed by IHC (D). In contrast, stainings reveal various layers of fibroblasts (FBs) (E; TE-7, brown) and endothelial cells (ECs) (F; CD31, 
brown) after seeding of the homograft. Cell nuclei were stained with hemalaun (D–F, purple). These are representative images of three inde-
pendent experiments. Scale bars: A, C = 30 µm; B = 40 µm; D–F = 100 µm.
 NONINVASIVE ANAlYSIS OF TISSUE-ENGINEErED HEArT VAlVES 173
levels of magnification are used for displaying the leaflets than 
for displaying the aortic regions to improve the visualization of 
changes in thickness. Increasing levels of thickness are indicated 
by red, green then blue coloring. Native (Figure 4A) and decel-
lularized leaflets (Figure 4B) as well as native (Figure 4D) and 
decellularized aortic regions (Figure 4E) showed comparable 
wall thicknesses between states of processing (region specific). 
In contrast, after seeding a distinct thickening of the leaflet (Fig-
ure 4C) and the aortic regions (Figure 4F) was observed.
Thickness Variance of PUHV
As described in the Materials and Methods section, the 
algorithms used to determine the wall thickness are based on 
topographic algorithms. Changes in thickness of seeded PUHV 
compared with native status are demonstrated in three-dimen-
sional graphics (Figure 5). Thickness variances are color coded; 
increasing levels of thickness are indicated by green, yellow, 
and then pink coloring. Decreasing levels of thickness are by 
turquoise and then blue coloring. In a vascular view (Figure 
5A), a ventricular view (Figure 5B), and a coronal view (Fig-
ure 5C), leaflets showed a thickening of up to 0.40 mm (pink). 
Analysis of the aortic wall revealed a thickening up to 0.16 mm 
after seeding (green), with several regions having thickened by 
up to 0.32 mm (red) variance.
In addition, Figure 6 demonstrates the cumulated variance 
distribution of seeded PUHV compared with native PUHV. The 
histogram correlates the absolute deviation to the surface area 
and revealed a thickening of up to 0.210 mm at 90% of the 
surface. Ten percentage of the surface showed a thickening 
between 0.210 mm and 0.400 mm, proving colonization at 
every position of the PUHV.
Furthermore, Figure 7 shows ROI measurements of FB-
seeded (A) and FB- and EC-seeded (B) PU scaffolds. At eight 
positions in each case, thicknesses are exemplary determined. 
The different contrast of the scaffold and the cellular cover-
age clearly demonstrate that a cell layer is available. More-
over, the FB- and EC-seeded (Figure 7B) scaffold revealed a 
thicker cellular coverage than the FB-seeded (Figure 7A) scaf-
fold, explainable by the presence of EC. Immunohistochemis-
try analyses support this declaration as well. Staining for TE-7 
of FB-seeded (Figure 7C) and staining for CD31 of FB- and 
EC-seeded (Figure 7D) scaffolds demonstrated the presence of 
FB (Figure 7C; brown) and a thin endothelial lining (Figure 7D; 
brown), respectively. Cell nuclei were stained with hemalaun 
(Figure 7C–D; purple).
Discussion
Conventional heart valve replacement using synthetic mate-
rials or unseeded biological valves is limited by viability, dura-
bility, and thrombogenicity. Tissue-engineered heart valves 
seeded with autologous cells constitute a promising alterna-
tive because of their potential antithromobogenicity effect and 
Table 1. Total Volume and Surface Area of BHV in Different 
States of Processing*
BHV State





Decellularized 2185 −0.5% 4904 +0.2%
Reseeded 2360 +8.6% 4775 −0.3%
Quantitative microcomputed tomography analysis demonstrated 
a decrease in volume and simultaneous increase in surface area af-
ter decellularization. Reseeding of decellularized BHV resulted in an 
expansion of volume accompanied with reduction of surface area. 
These are representative results of three independent experiments.
BHV, biological heart valve.
Figure 3. Thickness alteration of biological heart valve (BHV) in different processing states. The comparison of the native (A) and the 
decellularized (B) state of BHV shows a decrease in thickness at four exemplary positions. In contrast, the analysis in the reseeded state (C) 
compared with the decellularized and native state revealed an increase in thickness.
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good immunocompatibility. An effective quality control of 
heart valve implants is indispensable for the preoperative eval-
uation of tissue-engineered valves planned for implantation.
Despite the successful application of SEM and IHC for the 
assessment of seeding efficiency, these procedures are inappro-
priate for quality control of valves produced for implantation 
Figure 4. Wall thicknesses of biological heart valve (BHV) in different processing states. Micro-computed tomography analysis virtu-
ally generated cross-sections of BHV, illustrating the wall thickness in a color-coded manner. Different levels of magnification are used for 
displaying the valvular leaflets than for displaying the aortic wall regions to improve the visualization of changes in thickness in the different 
regions. Native (A) and decellularized leaflets (B) as well as native (D) and decellularized aortic regions (E) showed comparable wall thick-
nesses between states of processing (region specific). In contrast, reseeding results in a thickening of leaflets (C) and aortic wall regions (F). 
These are representative images of three independent experiments.
Figure 5. Thickness changes of polyurethane heart valve (PUHV) after seeding. Three-dimensional graphics represent changes in thick-
ness of seeded PUHV compared with native PUHV by color coding. The vascular view (A), the ventricular view (B), and the coronal view (C) 
reveal a clear thickening of the valvular leaflets and of the aortic wall (0.40 mm: pink; 0.32 mm: red, ≤ 0.16 mm: green). These are representa-
tive images of three independent experiments.
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because of the invasive nature of this method. Here, we provided 
evidence that µ-CT scanning is an attractive method for the non-
invasive evaluation of tissue-engineered heart valve constructs.
Microcomputed tomography as a modern imaging modal-
ity enables the visualization of tissue constructs with highly 
complex geometries, for example, the meniscus of a knee.27 
In fact for several years, µ-CT has been a standard tool for bio-
mechanical evaluation and optimization in orthopedic surgery. 
Jaecques et al.28 even examined the postimplantation adapta-
tion of bone tissue by µ-CT. The ability of µ-CT to visualize 
complex geometries precisely as tested in orthopedics is in line 
with results generated in this study. We successfully imaged 
Figure 6. Cumulated variance distribution of seeded polyurethane heart valve (PUHV) compared to native PUHV. Ninety percent of the 
surface revealed a thickening of up to 0.210 mm. Ten percent of the surface showed a thickening between 0.210 mm and 0.400 mm, indicat-
ing a total colonization of the PUHV. This is a representative histogram of three independent experiments.
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Figure 7. Region of Interest measurements of seeded polyurethane (PU) scaffolds. The thickness of the cellular coverage of fibroblasts 
(FB)-seeded (A) as well as FB- and endothelial cells (EC)-seeded (B) PU scaffolds were exemplary compared at eight positions. The FB- and 
EC-seeded (B) scaffold revealed a thicker cell layer than the FB-seeded (A) scaffold, indicating EC presence. Immunohistochemistry analyses 
also demonstrated a FB layer (C; TE-7, brown) with a thin endothelial lining (D; CD31, brown). Cell nuclei were stained with hemalaun (C–D; 
purple). Scale bars: C = 125 µm; D = 350 µm.
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the complex structure of our tissue-engineered heart valves. 
Further studies regarding the effect of µ-CT on the cell viabil-
ity should be carried out. Seeded heart valves were not main-
tained under physiological conditions such as 37°C and 5% 
CO2 during scanning. These conditions were classified as not 
required because of the short evaluation time in sterile contain-
ers. However, 10% of media was left in the glass container to 
avoid dehydration of the heart valve scaffolds during scanning.
We determined that there are many aspects that can be 
evaluated by µ-CT scanning. Besides the calculation of surface 
area and total volume, overlaying cross-sections of the valve 
at different states of processing provides important informa-
tion about region-specific alterations of the valves’ thickness. 
A deviation of cell layer thickness has been specially detected 
on the upper side of the cusps of the scaffold. This deviation is 
probably related to the seeding procedure. Cells are normally 
added into a seeding cylinder containing the scaffold. This pro-
cess leads probably to the formation of a cell clump on the 
upper side of the cusps. It is clearly not a deviation because the 
three-dimensional images are based on approximately 1,300 
images/side and valves were primarily fixed on Teflon support 
system for stabilization.
The results of REM analysis showed a confluent EC layer on 
the surface of the BHV. Moreover, the quantitative calculation 
enabled the definition of the minimum and maximum thickness 
of the seeded cell layer. This is applicable to decellularized 
BHV, decellularized homograft, and PUHV, and facilitates 
the verification of the success of different tissue engineering 
processes.
Other common methods for precise imaging are high-
frequency ultrasound (HFU) and magnetic resonance imag-
ing (MRI) of ferrumoxide-labeled cells.29,30 However, HFU 
and MRI only achieve a maximum resolution of 100 µm.30,31 
In contrast, current µ-CT scanners provide a resolution of 35 
µm, thus making µ-CT nearly three times more accurate than 
HFU and MRI.32 The algorithm used in this study to determine 
the surface topography includes a large number of neighbor-
ing voxels, resulting in topographic surface information with 
improved resolution. Typically, the topographic data gained 
from a 35-µm voxel resolution are accurate to at least a fac-
tor of four, providing an accurate topographic resolution of 
less than 10 µm. Using ROI technique resulted in very highly 
detailed images with a 9-µm voxel resolution a priori and a 
posteriori, allowing the detection of thin cell layers. An even 
higher detailed volume using ROI measurement (2-µm voxel 
resolution) is possible using a tailored glass container for sterile 
µ-CT scanning. This would be necessary to reduce the distance 
between the x-ray tube and the container to the minimum.
Furthermore, HFU is more adequate for use in the imag-
ing of fine tissue structures,29 than for creating virtual three-
dimensional models. Magnetic resonance imaging has several 
drawbacks. For example, the possibility of the dissolution of 
ferrum particles after implantation of an imaged construct 
could put patients at medical risk.33 A further disadvantage 
pertains to the labeling of the cells for imaging. For MRI visu-
alization, cells of tissue constructs must be labeled with mag-
netic particles such as ferrumoxide.33 These foreign molecules 
may potentially affect cell morphology, viability, and prolif-
eration. If used as a method for preoperative valve evaluation, 
altering these cellular characteristics could negate the benefit 
aimed for by implanting a tissue-engineered heart valve. The 
mentioned MRI linking system furthermore typically makes 
genetic manipulation of the cells necessary, to provide a coun-
terpart for linking of ferrumoxide particles. Immunoprecipita-
tion labeling systems are alternatives that do not necessitate 
genetic engineering.34 However, such labeling systems result 
in the distortion of cell morphology and in the alteration of 
intracellular processes, making this an unattractive approach.
In conclusion, we have demonstrated that µ-CT enables a 
quantitative calculation and quality control of seeding steps for 
tissue-engineered heart valve creation. Therefore, we are con-
vinced that µ-CT represents an effective, noninvasive imaging 
modality for the preoperative evaluation of tissue-engineering 
constructs.
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